NCT01677299View on ClinicalTrials.gov

Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

EFB0027 (metformin delayed release)

Comparison of enteric-coating to assess effect on PK

DRUG

EFB0026 (metformin immediate-release)

Active comparator

Trial Locations (2)

68502

Celerion, Inc., Lincoln

85283

Celerion, Inc., Tempe

Sponsors
All Listed Sponsors
lead

Elcelyx Therapeutics, Inc.

INDUSTRY